Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review

BACKGROUND: High prevalence of hepatocellular carcinoma (HCC) and typically poor prognosis of this disease that lead to late stage diagnosis when potentially curative therapies are least effective; therefore, development of an effective and systematic treatment is an urgent requirement. MAIN BODY: I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Cell Int
Autores principales: Hosseinzadeh, Faezeh, Verdi, Javad, Ai, Jafar, Hajighasemlou, Saieh, Seyhoun, Iman, Parvizpour, Frzad, Hosseinzadeh, Fatemeh, Iranikhah, Abolfazl, Shirian, Sadegh
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131874/
https://ncbi.nlm.nih.gov/pubmed/30214375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-018-0624-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares